Clinical Trial Update: Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of stereotactic body radiation therapy with cemiplimab (REGN2810) and/or ipilimumab before surgery for progressive advanced or oligometastatic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Libtayo (cemiplimab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Stage III Prostate Cancer, Stage IIIA Prostate Cancer | Phase 1 | Status: WITHDRAWN